Claudia G. Saunders

Consistently rank as Top Performer year after year. Presidents Club Winner, Cresset and Cresset One Winner 2020, Q4 2020 Rep of the Quarter, Silver Award 2021. Designated Cresset Climber as of last rankings for FY 2022.

• Increase HCP awareness of Rare Genetic Diseases by providing education on disease state, disease management and benefits of using Takeda infused therapies and available resources for patients and HCPs.
• Identify, establish and maintain strong relationships with physicians, and staff within accounts who treat Rare Disease patients.
• Assist clinical staff with steps necessary to get patient on therapy, which can include areas such as reimbursement, proper testing, and site of care determination.
• Manage all business-related activities within Gulf Coast, including achievement of sales goals, business planning, and expense control with focus around Health Care Organizations, including teaching institutions, Targeted HCPs and identifying and developing Sites of care serving patients.
• Apply selling skills, disease state awareness and clinical knowledge to enhance LSD business and build support for portfolio of products
• Analyze and apply market data to assess business opportunities and priorities, including relevant impact of regional health care market and patient dynamics.

Managed two of the most active territories of patients in the country for both Hematology and LSD. Constantly achieved over 100% of yearly metrics and goals. Led the Health Education Team in the number of HELLO (educational programs)Talks delivered in 2017 and 2018.

• Advanced patient self-care and clinical practice through clinical and non-clinical education on disease state, treatment management, and Takeda products per product label, and resources available for patients and providers.
• Provided support and professional expertise to internal and external customers i.e., specialty pharmacy partners, clinicians, and physicians by providing bilingual (English/Spanish) health education which includes planning and implementing educational seminars and training programs geared towards Spanish-speaking bleeding disorders and metabolic disorders community
• Developed strategic outreach planning, key account development, promotion of branded and non-branded educational programs to accomplish business growth and objectives.

Achieved 194% of required metrics for Q3 and Q4 in 2014. Managed largest territory of patients. Provided disease and product education to Crohn's Disease and Ulcerative Colitis patients. Developed local patient advocacy event opportunities by creating and/or supporting existing community networks and educational forums.

Utilized collaborative process of assessment, planning, implementation and evaluation, to engage, educate, and promote/influence members decisions related to achieving and maintaining optimal health status based on member’s health status/risks, education and support needs